Oramed Pharmaceuticals (ORMP) Receivables - Net (2011 - 2015)

Oramed Pharmaceuticals' (ORMP) quarterly Receivables - Net came in at $33000.0 in Q2 2015, down 57.69% on a QoQ basis from $78000.0 in Q3 2014.

Oramed Pharmaceuticals (ORMP) Receivables - Net (2011 - 2015) Analysis & Trends

Oramed Pharmaceuticals (ORMP) has 5 years of Receivables - Net data on file, last reported at $33000.0 in Q2 2015.

Quarterly Receivables - Net changed N/A year-over-year to $33000.0 in Q2 2015, while the trailing twelve-month figure through May 2015 was $33000.0 (changed N/A YoY) and the FY2014 annual result came in at $78000.0, changed N/A from the prior year.
Receivables - Net slipped to $33000.0 in Q2 2015, from $78000.0 in the prior quarter.
In the past five years, Receivables - Net ranged from a high of $542891.0 in Q3 2011 to a low of $33000.0 in Q2 2015.
A 5-year average of $185907.1 and a median of $86845.5 in 2011 frame the typical range for Receivables - Net.
Annual changes were most pronounced in 2012 — Receivables - Net slumped 83.85% — and 2013, when it surged 842.3%.
Tracing ORMP's Receivables - Net over 5 years: stood at $86000.0 in 2011, then fell by 11.69% to $75950.0 in 2012, then surged by 339.39% to $333719.0 in 2013, then slumped by 76.63% to $78000.0 in 2014, then tumbled by 57.69% to $33000.0 in 2015.
The last three Receivables - Net figures came in at $33000.0 (Q2 2015), $78000.0 (Q3 2014), and $333719.0 (Q2 2013), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Oramed Pharmaceuticals	197.61 Mn	197.61 Mn	-

Download Data